Udskriv Udskriv
Switch language
Hvidovre Hospital - en del af Københavns Universitetshospital

Non-invasive prenatal testing and maternal obesity - A review

Publikation: Bidrag til tidsskriftReviewpeer review


  1. Prenatal detection rate of major congenital heart defects in Copenhagen from 2015 to 2018

    Publikation: Bidrag til tidsskriftLetterpeer review

  2. Why we succeed and fail in detecting fetal growth restriction: A population-based study

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. Prevalence of Bicuspid Aortic Valve and Associated Aortopathy in Newborns in Copenhagen, Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

Vis graf over relationer

Noninvasive prenatal testing (NIPT) has become a popular screening test for the most common fetal aneuploidies. The performance of NIPT is affected by several factors including maternal obesity, which results in a greater rate of no-calls for obese pregnant women. Guidelines regarding NIPT in prenatal screening have been published, but with few and divergent recommendations on the issue. We aimed to review the medical literature, guidelines from scientific societies and information material from commercial NIPT providers on no-calls and maternal obesity. We systematically identified medical literature and guidelines from scientific societies using the database MEDLINE. Information material from commercial NIPT providers was found via a systematic search on Nine medical studies investigating the association between maternal obesity and NIPT no-calls were included. They all showed the same trend: increasing no-call rate with increasing maternal obesity. The no-call rate ranged from 0% to 4.2% for women with body mass index (BMI) 18.5-24.9 and from 5.4% to 70.1% for women BMI ≥40. We identified 17 scientific societies with guidelines and 13 commercial NIPT providers. All were checked for information material on no-calls and maternal obesity. To allow comparison, all guidelines were examined to answer the same three predefined questions. Of the 17 included scientific societies, 13 (76.5%) mentioned the association between maternal obesity and NIPT no-calls, two (11.8%) specified weight limits and three (17.6%) advised against NIPT for severely obese pregnant women. None of the 13 commercial NIPT providers provided specific recommendations, but four (30.8%) cite maternal obesity as a potential cause for a no-call. Because of the increasing number of patients in this group, we advocate updated recommendations to guide decision making in prenatal screening for obese pregnant women.

TidsskriftActa Obstetricia et Gynecologica Scandinavica
Udgave nummer6
Sider (fra-til)744-750
Antal sider7
StatusUdgivet - 1 jun. 2020

ID: 59614123